Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 447

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 447
---
 comply with our obligations in the agreements under which we license intellectual property rights from third parties or otherwise experience disruptions to our business relationships with our licensors, we could lose license rights that are important to our business. Disputes may arise between us and our licensors regarding intellectual property subject to a license agreement, including:

| • |     | the scope of rights granted under the license agreement and other interpretation-related issues; |

| • |     | whether and the extent to which our technology and processes infringe on intellectual property of the licensor 
 that is not subject to the licensing agreement;                                                                |

| • |     | our right to sublicense patents and other rights to third parties; |

| • |     | our diligence obligations under the license agreement and what activities satisfy those diligence obligations; |

- 299 -

| • |     | our right to transfer or assign the license; |

| • |     | the inventorship and ownership of inventions and know-how resulting from                     
 the joint creation or use of intellectual property by us and our licensors and partners; and |

| • |     | the priority of invention of patented technology. |

In addition, the agreements under which we license intellectual property or technology from third parties are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. Moreover, if disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected product or product candidates, which could have a material adverse effect on our business, financial conditions, results of operations, and prospects. In spite of our best efforts, our licensors might conclude that we have materially breached our license agreements and might therefore terminate the license agreements, thereby removing our ability to develop and commercialize products and technology covered by these license agreements. If these in-licensesare terminated, or if the underlying patents fail to provide the intended exclusivity, competitors would have the freedom to seek regulatory approval of, and to market, products identical to ours. This could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects. The patent protection and patent prosecution for our product